Y Loria

4.0k total citations
13 papers, 508 citations indexed

About

Y Loria is a scholar working on Cardiology and Cardiovascular Medicine, Small Animals and Molecular Biology. According to data from OpenAlex, Y Loria has authored 13 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Cardiology and Cardiovascular Medicine, 1 paper in Small Animals and 1 paper in Molecular Biology. Recurrent topics in Y Loria's work include Atrial Fibrillation Management and Outcomes (2 papers), Blood Pressure and Hypertension Studies (2 papers) and Chemical Synthesis and Analysis (1 paper). Y Loria is often cited by papers focused on Atrial Fibrillation Management and Outcomes (2 papers), Blood Pressure and Hypertension Studies (2 papers) and Chemical Synthesis and Analysis (1 paper). Y Loria collaborates with scholars based in France, Switzerland and Sweden. Y Loria's co-authors include Muriel Bonnet, Yves Agid, Marie Saint‐Hilaire, F Lhermitte, Claude Dubois, Jan Faergemann, Thomas C. Jones, R E Merceron, Esther Goldstein and A Lallemand and has published in prestigious journals such as Neurology, Clinical Pharmacology & Therapeutics and British Journal of Dermatology.

In The Last Decade

Y Loria

13 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y Loria France 8 225 68 65 65 64 13 508
RJ Dobbs United Kingdom 9 154 0.7× 39 0.6× 93 1.4× 28 0.4× 25 0.4× 16 401
J Cabezas-Cerrato Spain 11 94 0.4× 270 4.0× 66 1.0× 30 0.5× 19 0.3× 45 579
Constance Orme United States 6 422 1.9× 51 0.8× 50 0.8× 21 0.3× 512 8.0× 7 815
Xiaoqian Luan China 14 59 0.3× 16 0.2× 40 0.6× 152 2.3× 47 0.7× 46 581
Kathleen M. Randolph United States 12 52 0.2× 77 1.1× 17 0.3× 44 0.7× 21 0.3× 25 534
Daniele Bosone Italy 13 116 0.5× 16 0.2× 152 2.3× 53 0.8× 20 0.3× 38 541
R. A. Frowein Germany 13 300 1.3× 12 0.2× 20 0.3× 115 1.8× 107 1.7× 39 592
John Eisenhoffer Canada 13 149 0.7× 20 0.3× 22 0.3× 18 0.3× 47 0.7× 15 786
Edward A. Brunner United States 16 51 0.2× 25 0.4× 62 1.0× 26 0.4× 231 3.6× 47 764
E. B. French United Kingdom 14 20 0.1× 104 1.5× 77 1.2× 36 0.6× 60 0.9× 26 479

Countries citing papers authored by Y Loria

Since Specialization
Citations

This map shows the geographic impact of Y Loria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Loria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Loria more than expected).

Fields of papers citing papers by Y Loria

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Loria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Loria. The network helps show where Y Loria may publish in the future.

Co-authorship network of co-authors of Y Loria

This figure shows the co-authorship network connecting the top 25 collaborators of Y Loria. A scholar is included among the top collaborators of Y Loria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Loria. Y Loria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Sabaté, Jean‐Marc, Didier Bouhassira, Cécile Poupardin, et al.. (2007). Sensory signalling effects of tegaserod in patients with irritable bowel syndrome with constipation1. Neurogastroenterology & Motility. 20(2). 134–141. 37 indexed citations
2.
Faergemann, Jan, et al.. (1996). Pityrosporum ovale(Malassezia furfur)as the causative agent of seborrhoeic dermatitis: new treatment options. British Journal of Dermatology. 134. 12–15. 47 indexed citations
3.
Loria, Y, et al.. (1992). Isradipine for the treatment of hypertension following coronary artery bypass graft surgery: a randomized trial versus sodium nitroprusside.. PubMed. 9(4). 293–305. 6 indexed citations
4.
Dubois, Claude, et al.. (1991). Comparison of nicardipine and sodium nitroprusside in the treatment of paroxysmal hypertension following aortocoronary bypass surgery. Journal of Cardiothoracic and Vascular Anesthesia. 5(4). 357–361. 38 indexed citations
5.
Guize, L, et al.. (1990). Electrophysiologic Effects of Intravenous Nicardipine on Sinus Node Function and Conduction in Humans. Journal of Cardiovascular Pharmacology. 15(1). 130–137. 4 indexed citations
6.
Bonnet, Muriel, Y Loria, Marie Saint‐Hilaire, F Lhermitte, & Yves Agid. (1987). Does long‐term aggravation of Parkinson's disease result from nondopaminergic lesions?. Neurology. 37(9). 1539–1539. 230 indexed citations
7.
Goldstein, Esther, et al.. (1985). Follow-Up of Children Born of Bromocriptine-Treated Mothers. Hormone Research. 22(3). 239–246. 66 indexed citations
8.
Bellet, M, Y Loria, & A Lallemand. (1985). First-Step Treatment of Mild to Moderate Uncomplicated Essential Hypertension by a New Calcium Antagonist: Nicardipine. Journal of Cardiovascular Pharmacology. 7(6). 1149–1153. 26 indexed citations
9.
Loria, Y, et al.. (1982). Antihypertensive Effects and Plasma Levels of Guanfacine in Man. The Journal of Clinical Pharmacology. 22(8-9). 385–390. 3 indexed citations
10.
Lebeau, B., et al.. (1982). [Preventive treatment of asthma with ketotifen : an analysis of 1 791 cases treated in general practice].. PubMed. 38(2). 125–9. 3 indexed citations
11.
Weiss, Yves A., et al.. (1979). Guanfacine kinetics in patients with hypertension. Clinical Pharmacology & Therapeutics. 25(3). 283–293. 17 indexed citations
12.
Weiss, Y, et al.. (1977). Pharmacokinetics and Hepatic Extraction Ratio of Pindolol in Hypertensive Patients with Normal and Impaired Renal Function. The Journal of Clinical Pharmacology. 17(8-9). 501–508. 28 indexed citations
13.
Lallemand, A, et al.. (1977). [Validation by factor analysis of clinical evaluation scale of disorders of cerebral senescence. Use in a therapeutic trial].. PubMed. 32(2). 173–80. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026